Skip to content
Open access

Osteosarcopenia: More Than the Sum of Its Parts? A Community-Based Study Across Sarcopenia Definitions

Oct 2026 · Calcified Tissue International · Vol 117 · 0 citations · 22 references
Medicine

TL;DR

There was no statistically significant evidence that osteoporosis and sarcopenia co-occurred more often than expected under statistical independence, across several sarcopenia definitions, although estimates for confirmed sarcopenia were imprecise.

Abstract

Osteosarcopenia, the co-existence of osteoporosis and sarcopenia, is described as a geriatric syndrome arising from shared determinants of muscle and bone. We asked how far the prevalence of sarcopenia and osteosarcopenia depends on the definition of low muscle mass, whether osteoporosis and sarcopenia co-occur more often than expected under statistical independence, and whether the muscle–bone relationship is expressed in areal bone mineral density (BMD) or in femoral geometry. Cross-sectional study of 649 community-dwelling adults aged 65 years and over (72% women; mean age 71.5 years; mean body mass index (BMI) 29.6 kg/m2) assessed with dual-energy X-ray absorptiometry (GE Lunar iDXA), grip dynamometry (Jamar Hydraulic Hand Dynamometer) and the Short Physical Performance Battery. Osteoporosis followed World Health Organization criteria. Sarcopenia was classified according to EWGSOP2, and low muscle mass was defined three ways (appendicular lean mass (ALM)/height2; absolute ALM; and the Foundation for the National Institutes of Health (FNIH) ALM/BMI index). Observed co-occurrence was compared with the value expected under independence (Fisher exact test, odds ratios (OR) with 95% confidence intervals (CI)); for the best-powered analysis the two one-sided tests (TOST) equivalence procedure using pragmatic equivalence bounds of OR 0.5 to 2.0. Hip structural analysis provided section modulus and cross-sectional area. Low muscle mass ranged from 3.7 to 15.7%, and confirmed sarcopenia from 1.4 to 4.2%, according to the metric. Osteoporosis prevalence was 17.6% (95% CI 14.9 to 20.8). Under none of the sarcopenia definitions was there statistically significant evidence of excess co-occurrence (Fisher p = 0.50 to 1.00), although observed overlap under the absolute-ALM definition was slightly above the independence expectation. For probable sarcopenia (low grip strength), the best-powered comparison, the OR was 0.89 (95% CI 0.47 to 1.67) and equivalence within broad OR bounds of 0.5 to 2.0 was supported (90% CI 0.52 to 1.51; TOST p = 0.037); equivalence was not supported under narrower bounds. Appendicular lean mass was not associated with areal BMD after adjustment for body size (femoral neck standardised β = 0.03, 95% CI − 0.18 to 0.24) but was associated with femoral section modulus substantially more strongly in men than women (globally standardised interaction Δβ = 0.30, 95% CI 0.15 to 0.44, p < 0.001). In this community sample, there was no statistically significant evidence that osteoporosis and sarcopenia co-occurred more often than expected under statistical independence, across several sarcopenia definitions, although estimates for confirmed sarcopenia were imprecise. The muscle-bone association was more apparent for femoral geometry than areal BMD and was seen predominantly in men. These findings do not support assuming that low bone mass and low muscle mass identify the same individuals, but they concern statistical co-occurrence and do not establish biological independence.

Read PDF

Similar papers

Open access Oct 2026

Prevalence of osteosarcopenia and associated factors among older Vietnamese outpatients: A cross-sectional study

Background Osteosarcopenia – the concurrent presence of sarcopenia and low bone mass, including osteopenia or osteoporosis – is emerging as a significant health issue in aging populations. This study aimed to estimate the prevalence of osteosarcopenia and identify factors associated with prevalent osteosarcopenia among...

L. H. Ngo, H. T. Hoang, H. T. Nguyen et al. · 0 citations
Open access Sep 2026

Sarcopenia, its components and fracture risk in people living with human immunodeficiency virus

SUMMARY OBJECTIVE: The aim of this study was to evaluate the relationship between sarcopenia and its components with fracture risk in people living with human immunodeficiency virus, and to assess the association with sociodemographic and clinical characteristics. METHODS: This cross-sectional study was conducted with...

Edivaldo Cangussu Meira, Jaine Alves Ximenez, Marcia Midori Shinzato et al. · 0 citations
Open access Oct 2026

CO-54 | DECREASED BONE MINERAL DENSITY IN HEMOPHILIA IS NOT CORRELATED WITH INCREASED RISK OF FRACTURES

Background and Aims. A decrease in bone mineral density (BMD) is observed in people with hemophilia (PwH) due to several risk factors, including arthropathy causing limited mobility as well as chronic viral infections (i.e., HCV and HIV). The aim of this study was to evaluate BMD and bone microarchitecture (as per trab...

M. Fasulo · 0 citations
Open access Nov 2026

Bone Mineral Density Across the Menopausal Transition: A Multi-Ethnic DXA Study from the Northern Emirates, UAE

The prevalence of osteopenia and osteoporosis across menopausal status and the relative contributions of body mass index (BMI), ethnicity, and medical history to low BMD are quantified in this multi-ethnic cohort from the Northern Emirates.

Ayshath Fazna Fahimi, Kumaraguruparan Gopal, R. Muthukrishnan et al. · 0 citations
Open access Oct 2026

Association between the FRAX algorithm and bone mineral density in postmenopausal women with sarcopenia

   Background. The current version of the Fracture Risk Assessment Tool (FRAX) does not account for the presence of sarcopenia. In addition, the assessment of nutritional status within the algorithm is limited to body weight and body mass index (BMI), which may be overestimated in this patient population due to age-...

A. Podkhvatilina, I. Nikitin, S. Shchelykalina · 0 citations
Open access Nov 2026

Association between MASLD and bone mineral density in Chinese aged 20-50: a cross-sectional study

Hepatic osteodystrophy (HOD) is a metabolic bone disorder characterized by bone loss in patients with chronic liver diseases (CLDs). Metabolic dysfunction-associated steatotic liver disease (MASLD) is among the most common CLDs, and its burden is increasing in younger populations; however, its association with bone...

Jing Wu, Jia-Cheng Li, Yu-Qi Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.